Navigation Links
Case Western Reserve researcher discovers new 'anti-pathogenic' drugs to treat MRSA
Date:9/16/2010

CLEVELAND September 16, 2010 Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by preventing the production of toxins that cause disease.

Infections of MRSA are a growing public health problem causing 20,000 deaths per year in the U.S. alone. MRSA is the most prevalent bacterial pathogen in hospital settings and in the community at large. The problem has become increasingly severe due to the fact that the bacteria develop resistance to antibiotics. Currently, there are only two antibiotics available to treat MRSA (vancomycin and linezolid) and strains are emerging that are resistant even to these two remaining antibiotics. As result, healthcare providers are running out of options to treat patients suffering from antibiotic-resistant infections, creating a dire need for alternative treatments and approaches.

"Staph bacteria are ubiquitous and normally do not cause infections, however, occasionally these bacteria become harmful due to their secretion of toxins," said Dr. Shoham. "We have discovered potential "anti-pathogenic" drugs that block the production of toxins, thus rendering the bacteria harmless. Contrary to antibiotics, these new anti-pathogenic drugs do not kill the bacteria. And since the survival of the bacteria is not threatened by this approach, the development of resistance, like that to antibiotics, is not anticipated to be a serious problem."

Dr. Shoham identified a bacterial protein, known as AgrA, as the key molecule responsible for the release of toxins. AgrA, however, needs to be activated to induce toxin production. His goal was to block the activation of AgrA with a drug, thus preventing the cascade of toxin release into the blood that can lead to serious infections throughout the body.

The screening for AgrA inhibitors was initially carried out in a computer by docking a library of 90,000 compounds and finding out which compounds would fit best into the activation site on AgrA. Subsequently, about one hundred of the best scoring compounds were acquired and tested in the laboratory for inhibition of the production of a toxin that ruptures red blood cells.

Seven of these compounds were found to be active. Testing compounds bearing chemical similarity to the original compounds lead to the discovery of additional and more potent compounds.

More than a dozen active compounds have been discovered by this method. The best drug candidate reduces red blood cell rupture to 12% of the value without the drug at a concentration of 10 g/mL, without affecting bacterial growth..

"It is possible to inhibit virulence of MRSA without killing the bacteria," continued Dr. Shoham. "Such anti-pathogenic drugs may be used for prophylaxis or therapy by themselves or in combination with an antibiotic."

This research was carried out in the laboratory of Dr. Menachem Shoham in the Department of Biochemistry at the Case Western Reserve University School of Medicine in Cleveland, Ohio. Funding was provided by grants from the Steris Corporation and from the American Heart Association.

The results were presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston Conference Center earlier this week.


'/>"/>

Contact: Christina DeAngelis
christina.deangelis@case.edu
216-368-3635
Case Western Reserve University
Source:Eurekalert

Related biology news :

1. Case Western Reserve geneticist receives prestigious NIH Directors Pioneer Award
2. Pancreatic cancers use fructose, common in the Western diet, to fuel their growth
3. UT Southwestern researchers find key step in bodys ability to make red blood cells
4. Case Western Reserve awarded $4.7 million from Defense Advanced Research Projects Agency
5. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
6. Temperature and salt levels of the Western Mediterranean are on the increase
7. UT Southwestern researchers find mechanism that may stop E. coli from developing in cattle
8. UT Southwestern researchers identify key molecular step to fighting off viruses
9. Case Western Reserve team discovers smart insulin molecule
10. UT Southwesterns BioCenter driving biotech, medical innovation in North Texas
11. New brain nerve cells key to stress resilience, UT Southwestern researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)...  CES 2017 – Valencell , the leading ... the launch of two new versions of its ... sensor modules that incorporate the best of Valencell,s ... The two new designs include Benchmark BE2.0, a ... Benchmark BW2.0, a 2-LED version of its original ...
(Date:12/20/2016)... Dec, 20, 2016   Valencell , the ... and STMicroelectronics (NYSE: STM), a global semiconductor ... applications, announced today the launch of a new, ... wearables that includes ST,s compact SensorTile ... biometric sensor system. Together, SensorTile and Benchmark ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December ... leading global financial services provider, today announced an agreement with ... behavioural biometrics, to join forces. The partnership will enable clients ... strategies in compliance with local data protection regulation. ... In order to ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... Los Angeles, California (PRWEB) , ... January 11, ... ... collaborative approach to support fertility specialists with accurate and reliable preimplantation genetic screening ... and we have achieved excellent results,” says Ovation Fertility Genetics Scientific Director ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... optics and photonics , are commending the U.S. Congress and President Obama for ... by the President of the American Innovation and Competitiveness Act (AICA). , The ...
(Date:1/11/2017)... ... January 11, 2017 , ... With ... healthcare systems more than $23.7 billion, healthcare systems are looking to provide ... the most common sepsis-causing pathogens are bacteria and the yeast pathogen Candida, which ...
(Date:1/11/2017)... ... January 11, 2017 , ... Microbial genomics leader uBiome, ... Its most recent microbiome impact grant award has been made to Dr. Eon ... long-term use of oral antibiotics, prescribed for skin conditions, on the gut microbiome. ...
Breaking Biology Technology: